Goyescas Broncovac 1
NDC Package 11856-0016-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Goyescas Broncovac 1 is a medication used as Active Ingredients: Purpose(in each 5 ml. Marketed by Goyescas Of Fla, this product is identified by NDC 11856-0016 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
11856-0016-1
Package Description
1 BOTTLE in 1 BOX / 177 mL in 1 BOTTLE
Product Code
11856-0016
11-Digit Billing Format
11856001601
RxNorm Crosswalk
  • RxCUI: 1726414 - dextromethorphan HBr 10 MG / guaiFENesin 50 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution
  • RxCUI: 1726414 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 10 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
  • RxCUI: 1726414 - dextromethorphan hydrobromide 10 MG / guaifenesin 50 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution
  • RxCUI: 1726414 - dextromethorphan hydrobromide 30 MG / guaifenesin 150 MG / phenylephrine hydrochloride 15 MG per 15 ML Oral Solution

Clinical Specifications

Proprietary Name
Goyescas Broncovac 1 Cough And Cold
Dosage Form
-
Usage Information
This product is used as Active Ingredients: Purpose(in each 5 ml. tsp)Dextromethorphan HBr USP 10mg Cough SuppresantGuaifenesin USP 50mg ExpectorantPhenylephrine HCI USP 5mg Nasal Decongestant

Regulatory & Marketing

Labeler Name
Goyescas Of Fla
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-01-1958
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 11856-0016-1 identifies a specific commercial package of 1 bottle in 1 box / 177 ml in 1 bottle of Goyescas Broncovac 1 Cough And Cold, labeled by Goyescas Of Fla. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Goyescas Of Fla on August 01, 1958. The current certification is valid through December 31, 2017.

How is this Goyescas Of Fla product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 11856001601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
11856-0016-1
11-Digit CMS (5-4-2)
11856-0016-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.